Glioblastoma is an aggressive primary tumor of the central nervous system. This review will focus on clinical developments and management of newly diagnosed disease, including a discussion about the incorporation of molecular features into the classifi cation of glioblastoma. Such advances will continue to shape our thinking about the disease and how to best manage it. With regards to treatment, the role of surgical resection, radiotherapy, chemotherapy, and tumortreating fi elds will be presented. Pivotal studies defi ning our current standard of care will be highlighted, as will key ongoing trials that may infl uence our management of glioblastoma in the near future.
|Original language||English (US)|
|Number of pages||10|
|Journal||ONCOLOGY (United States)|
|State||Published - Jan 1 2019|
ASJC Scopus subject areas
- Cancer Research